Fes Researchers Investigate Promising Molecules Against Stomach Cancer
Researchers from Sidi Mohammed Ben Abdellah University in Fes have embarked on a groundbreaking study aimed at identifying chemical compounds that can effectively target stomach cancer cells. This research combines laboratory experiments with computer simulations, allowing the team to select compounds that may be further developed in subsequent research phases. The findings of this study, published on September 1, 2026, in the Beni-Suef University Journal of Basic and Applied Sciences from Springer Nature, highlight the potential of derivatives from the hydrazide-hydrazone class. The researchers specifically focused on assessing these compounds against human stomach cancer cells known as MGC803.
The team utilized both in vitro testing of the compounds on cancer cells and computational tools to predict how these molecules would interact with proteins associated with the disease. Additionally, they evaluated important characteristics such as absorption, toxicity, and stability within the human body. This innovative approach allows for the screening of a vast number of molecules before advancing to more complex experimental stages, focusing on compounds that show the most promising indicators for further study.
Testing Molecules and Optimizing Effectiveness
The researchers began by comparing the chemical structures of the various compounds and assessing their effects on cancer cells to identify modifications that might enhance their efficacy. Using 3D models, the team predicted the impact of minor changes in the molecular composition and subsequently suggested new compounds based on the computational results obtained. This method significantly narrows down the selection process, avoiding the need to synthesize and test large quantities of compounds in the laboratory.
The study also examined how the compounds might behave within the body, assessing parameters such as absorption, distribution, metabolism, and excretion, in addition to potential toxicity. A compound may exhibit effectiveness against cancer cells in the lab, but it must also possess other properties that allow for its further development, making the evaluation of these aspects a crucial part of the candidate selection process.
The researchers leveraged computer simulations to investigate how certain molecules bind to proteins that may be involved in the growth of cancer cells. These simulations help visualize the molecular site within the protein and estimate the strength of the interaction, while also monitoring the stability of this bond over longer simulations that mimic molecular movements. The team compared these results with biological tests on stomach cancer cells to determine if the compounds that appeared promising in the computational models maintained their activity in the laboratory setting.
This dual approach enables early exclusion of less viable compounds and allows for a focus on those demonstrating superior results across multiple tests. Moreover, the researchers employed biological network analysis to identify proteins and pathways that could be affected by these compounds, aiming to develop a broader understanding of their potential mechanisms of action.
As the compounds studied remain in early testing stages, further tests on additional cell types are required. This includes evaluating their effects on healthy cells, assessing toxicity, determining appropriate dosages, and understanding their movement within the organism. Following these stages, more advanced research phases are necessary before any compound can be tested on humans, a process that may eliminate many initially promising molecules. The work accomplished in Fes illustrates a growing trend that merges chemistry with biological experimentation and computational tools in the search for anticancer agents, enabling laboratory efforts to focus on molecules that exhibit the best preliminary indicators of success.
The next phase will depend on the ability of the selected compounds to sustain their activity in broader tests, as well as their potential impact on cancer cells while maintaining acceptable safety levels.
As reported by hespress.com.
